| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses | 304,133 | |||
| Deposit | 7,500 | |||
| Cash and cash equivalents | 1,792,856 | |||
| Supplies used for r&d and manufacturing | 518,040 | |||
| Total current assets | 2,622,529 | |||
| Property and equipment, net | 6,578,679 | |||
| Operating lease right-of-use assets | 1,332,096 | |||
| Patent costs, net | 130,585 | |||
| Finance lease right-of-use assets | 5,998,731 | |||
| Deposits | 2,319,101 | |||
| Supplies used for r&d and manufacturing, noncurrent | 1,354,478 | |||
| Total assets | 20,336,199 | |||
| Operating lease liabilities, current portion | 187,739 | |||
| Finance lease liabilities, current portion | 2,205,972 | |||
| Accrued expenses | 475,602 | |||
| Accounts payable | 1,577,215 | |||
| Due to employees | 1,169,520 | |||
| Total current liabilities | 5,616,048 | |||
| Other liabilities | 125,000 | |||
| Operating lease liabilities, net of current portion | 1,298,398 | |||
| Finance lease liabilities, net of current portion | 6,271,813 | |||
| Total liabilities | 13,311,259 | |||
| Accumulated deficit | -533,322,016 | |||
| Common stock, 0.01 par value 600,000,000 shares authorized 5,321,341 and 2,126,237 shares issued and outstanding at june 30, 2025 and september 30, 2024, respectively | 53,214 | |||
| Additional paid-in capital | 540,293,742 | |||
| Total stockholders' equity | 7,024,940 | |||
| Total liabilities and stockholders' equity | 20,336,199 | |||
CEL SCI CORP (CVM)
CEL SCI CORP (CVM)